CFTR and cystic fibrosis: The use of intestinal organoids in CF research has increased due to their physiological relevance, being derived from individuals with CF, and to the ability to correlate both basal CFTR function with disease severity and their response to drugs to predict clinical benefit, through the forskolin-induced swelling (FIS) assay [34].